Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-130-5 | CAS number: 68187-85-9
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 Aug - 28 Sep 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted Jul 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- Mar 2003
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- other: EC No 440/2008, part B. Skin Sensitization: Guinea-Pig Maximization Test (GPMT)
- Version / remarks:
- May 2008
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- other: JMAFF Guidelines
- Version / remarks:
- 2000
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The guinea pig maximization test was selected since the available alternative in vitro tests for skin sensitization are not applicable for the test item due to its intrinsic properties. The guinea pig maximization test was selected as animal test since the test item is a fatty acid and the Local Lymph Node Assay as preferred animal alternative has shown to provide false positive results for fatty acids.
Test material
- Reference substance name:
- Fatty acids, tall-oil, esters with ethylene glycol
- EC Number:
- 269-130-5
- EC Name:
- Fatty acids, tall-oil, esters with ethylene glycol
- Cas Number:
- 68187-85-9
- Molecular formula:
- C38H66O4 C38H64O4 C40H68O4 C40H70O4 C38H68O4
- IUPAC Name:
- 2-[(9Z)-octadec-9-enoyloxy]ethyl (9Z)-octadec-9-enoate; 2-[(9Z)-octadec-9-enoyloxy]ethyl (9Z,12Z)-octadeca-9,12-dienoate; 2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]ethyl (9Z,12Z)-octadeca-9,12-dienoate
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River France, L’Arbresle, France
- Microbiological status of animals, when known: SPF
- Age at study initiation: approximately 4 - 5 weeks
- Weight at study initiation: 283 - 330 g
- Housing: Animals were group housed (up to 5 animals of the same sex and same dosing group together) in labeled Noryl cages (Tecniplast; 74 cm x 54 cm x 25 cm height) containing sterilized sawdust as bedding material (Lignocel S 8-15, JRS - J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany) equipped with water bottles.
- Diet: Complete maintenance diet for guinea pigs (MS-H, SSNIFF® Spezialdiäten GmbH, Soest, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 - 23
- Humidity (%): 43 - 73
- Air changes (per hr): ten or greater
- Photoperiod (hrs dark / hrs light): 12/12
- IN-LIFE DATES: From: 10 Aug 2018 To: 28 Sep 2018
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100%
- Day(s)/duration:
- single injection on Day 1
- Adequacy of induction:
- non-irritant substance, but skin pre-treated with 10% SDS
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100%
- Day(s)/duration:
- Applied on Day 7, 48 h
- Adequacy of induction:
- non-irritant substance, but skin pre-treated with 10% SDS
Challenge
- No.:
- #1
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100%
- Day(s)/duration:
- 1 day
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 5 (control) and 10 (treatment group)
- Details on study design:
- RANGE FINDING TESTS:
To determine a suitable concentration for the intradermal induction in the main study, a series of four test item concentrations (10, 20, 50 and 100%) was selected. A total of 2 female guinea pigs each received two different concentrations (50 and 100%) in duplicate (0.1 mL/site) in the clipped scapular region. The injection sites were assessed for irritation 24 and 48 hours after treatment. The degree of erythema at the injection sites was recorded 24 and 48 h after injection.
To determine a suitable concentration for the epicutaneous induction in the main study, a series of four test item concentrations was tested, the highest concentration being the undiluted test item. Two different concentrations were applied (0.5 mL each per animal to the clipped flank, using Metalline patches (2x3 cm) mounted on Medical tape which were held in place with Micropore tape and subsequently Coban elastic bandage. The animals receiving intradermal injections were treated with the lowest concentrations and two other animals with the highest concentrations. The degree of erythema at the injection sites was recorded 24 and 48 h after injection.
Based on the results, the test item concentration selected for the main study was the undiluted test item for the intradermal and epidermal induction and for the challenge. No signs of irritation were observed to the undiluted test item dosed epidermally and therefore, the test site of all animals of the main study were treated with 10% SDS approximately 24 hours before the epidermal induction, to provoke a mild inflammatory reaction.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA/water
Injection 2: unchanged (100%) test material
Injection 3: unchanged (100%) test material in a 1:1 mixture (v/v) FCA/water
Epicutaneous: the undiluted test substance
- Control group:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA/water
Injection 2: corn oil
Injection 3: corn oil in a 1:1 mixture (v/v) FCA/water
Epicutaneous: blank patch
- Site: shoulder region (intradermal and epicutaneous)
- Frequency of applications: Day 0 (intradermal) and Day 7 (epicutaneous)
- Duration: Days 0 - 7
- Concentrations: intradermal and epicutaneous: undiluted test material
B. CHALLENGE EXPOSURE
- No. of exposures: 1 (challenge)
- Day(s) of challenge: 21
- Exposure period: 24 h
- Test groups: test substance in arachis oil BP and test substance only
- Site: one flank (test substance only), other flank (vehicle)
- Concentrations: undiluted test material
- Evaluation: 24 and 48 h after patch removal - Positive control substance(s):
- no
Results and discussion
- Positive control results:
- A reliability check is carried out at regular intervals to check the sensitivity of the test system and the reliability of the experimental techniques as used by the testing facility. In this study, performed in July 2017, females of the Dunkin Hartley guinea pig (from Charles River France, L’Arbresle, France) were checked for the sensitivity to alpha-hexylcinnamaldehyde, technical grade.
The skin reactions observed in 10/10 animals in response to the 50% test item concentration in the challenge phase were considered indicative of sensitisation, based on the absence of any response in the control animals. These results lead to a sensitisation rate of 100 percent to the 50% concentration. From these results, it was concluded that the female guinea pig of the Dunkin Hartley strain is an appropriate animal model for the performance of studies designed to evaluate the sensitizing potential of a test item in a Maximization type of test.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Induction: undiluted (intradermal + epicutaneous); Challenge: undiluted (epicutaneous)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Induction: 0% (intradermal + epicutaneous); Challenge: undiluted
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Induction: undiluted (intradermal + epicutaneous); Challenge: undiluted (epicutaneous)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Induction: 0% (intradermal + epicutaneous); Challenge: undiluted
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Group:
- positive control
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
Table 1: Induction readings
Control Animals |
||||||||
Animal Number |
Intradermal injections (readings Day 3) |
Epidermal exposure |
||||||
1:1 Mixture of FCA and water for injection |
Corn oil |
1:1 Mixture of FCA and corn oil |
Corn oil |
|||||
Erythema |
Signs of necrosis |
Erythema |
Signs of necrosis |
Erythema |
Signs of necrosis |
Erythema |
Oedema |
|
41 |
0 |
|
0 |
|
0 |
|
1 |
0 |
42 |
|
5 |
0 |
|
0 |
|
1 |
0 |
43 |
|
2 |
0 |
|
0 |
|
1 |
0 |
44 |
|
2 |
0 |
|
0 |
|
1 |
0 |
45 |
|
3 |
0 |
|
0 |
|
1 |
0 |
Experimental Animals |
||||||||
Animal Number |
Intradermal injections (readings Day 3) |
Epidermal exposure |
||||||
1:1 Mixture of FCA and water for injection |
Undiluted test item |
1:1 Mixture of FCA and |
Undiluted test item |
|||||
Erythema |
Signs of necrosis |
Erythema |
Signs of necrosis |
Erythema |
Signs of necrosis |
Erythema |
Oedema |
|
46 |
|
1 |
0 |
|
|
5 |
1 |
0 |
47 |
1 |
|
1 |
|
|
3 |
2 |
0 |
48 |
1 |
|
1 |
|
|
2 |
2 |
0 |
49 |
1 |
|
1 |
|
|
3 |
1s |
0 |
50 |
|
3 |
0 |
|
|
5 |
1s |
0 |
51 |
|
2 |
0 |
|
0 |
|
2s |
1 |
52 |
|
2 |
0 |
|
0 |
|
1 |
1 |
53 |
|
4 |
|
2 |
|
6 |
1 |
0 |
54 |
1 |
|
1 |
|
|
2 |
2 |
1 |
55 |
|
2 |
|
3 |
|
2 |
1s |
1 |
FCA = Freunds' Complete Adjuvant, s. = Scaliness.
Grading erythema:
0 = No erythema
1 = Slight erythema (barely perceptible)
2 = Well-defined erythema
Grading Oedema:
0 = No oedema
1 = Slight oedema (barely perceptible)
Table 2: Challenge readings
Animal number |
Day 24 |
Day 25 |
Comments |
||
Undiluted test item |
Vehicle |
Undiluted test item |
Vehicle |
||
Control |
|
|
|
|
|
41 |
0 |
0 |
0 |
0 |
|
42 |
0 |
0 |
0 |
0 |
|
43 |
0 |
0 |
0 |
0 |
|
44 |
0 |
0 |
0 |
0 |
|
45 |
0 |
0 |
0 |
0 |
|
Experimental |
|
|
|
|
|
46 |
0 |
0 |
0 |
0 |
not sensitized |
47 |
0 |
0 |
0 |
0 |
not sensitized |
48 |
0 |
0 |
0 |
0 |
not sensitized |
49 |
0 |
0 |
0 |
0 |
not sensitized |
50 |
0 |
0 |
0 |
0 |
not sensitized |
51 |
0 |
0 |
0 |
0 |
not sensitized |
52 |
0 |
0 |
0 |
0 |
not sensitized |
53 |
0 |
0 |
0 |
0 |
not sensitized |
54 |
0 |
0 |
0 |
0 |
not sensitized |
55 |
0 |
0 |
0 |
0 |
not sensitized |
Grading challenge reactions:
0 = No visible change
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
